Table of Contents
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 2, 2004
ARQULE, INC.
| Delaware | 000-21429 | 04-3221586 | ||
| (State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
19 Presidential Way
Woburn, MA
01801
(781) 994-0300
| Item 5. Other Events and Regulation FD Disclosure | ||||||||
| Item 7. Financial Statements, Pro Forma Financial Information and Exhibits | ||||||||
| SIGNATURES | ||||||||
| EX-99.1 PRESS RELEASE DATED APRIL 2, 2004 | ||||||||
Table of Contents
Item 5. Other Events and Regulation FD Disclosure
ArQule, Inc. today announced formation of a strategic alliance with the Roche Group in the field of oncology and revised its financial guidance for 2004. The text of the press release announcing the alliance and revised guidance is filed as Exhibit 99.1 hereto.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits
(c) Exhibits
99.1 Text of Press Release dated April 2, 2004.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ARQULE, INC. (Registrant) | ||||
| /s/ Stephen A. Hill | ||||
| Stephen A. Hill President and Chief Executive Officer | ||||
Date: April 2, 2004